Skip to content

ERNA

Ernexa Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.83
+1.86%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
1.95x
Price / sales
Price / cash flow
-0.71x

Enterprise value

Enterprise value
$1.6M
EV / sales
EV / EBITDA
-0.09x
EV / EBIT
-0.13x
Market cap
$6.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026